There are 2949 resources available
769P - APOBEC signatures and high tumour mutational burden as predictors of clinical outcomes and response to therapy in patients with urothelial carcinoma
Presenter: Divya Natesan
Session: E-Poster Display
Resources:
Abstract
770P - Prognostic and predictive value of ribonucleotide reductase subunit family M1/M2 in urothelial carcinoma
Presenter: Jinan Guo
Session: E-Poster Display
Resources:
Abstract
772P - Phase Ib/II study of durvalumab plus guadecitabine in advanced clear cell renal cell cancer (ccRCC)
Presenter: Yousef Zakharia
Session: E-Poster Display
Resources:
Abstract
771P - Efficacy of enfortumab vedotin in populations of interest among patients with advanced urothelial cancer
Presenter: VADIM KOSHKIN
Session: E-Poster Display
Resources:
Abstract
773P - Cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) after platinum chemotherapy: Safety and preliminary activity of the open-label, single-arm, phase II ARCADIA trial
Presenter: Laura Marandino
Session: E-Poster Display
Resources:
Abstract
774P - Adoption of immune checkpoint inhibitors (ICIs) in bladder cancer: Findings from a real-world study in EU5
Presenter: Kriti Jindal
Session: E-Poster Display
Resources:
Abstract
775P - Whole blood transcriptomic profiling to predict response to immunotherapy in metastatic urothelial cancer
Presenter: Sandra Van Wilpe
Session: E-Poster Display
Resources:
Abstract
776P - Phase II trial of concurrent nivolumab in urothelial bladder cancer with radiation therapy in localized/locally advanced disease for chemotherapy ineligible patients [NUTRA trial]
Presenter: Ulka Vaishampayan
Session: E-Poster Display
Resources:
Abstract
777P - Decrease in derived neutrophil-to-lymphocyte ratio (dNLR) related to immune checkpoint inhibitors (ICI) benefit in patients with metastatic urothelial carcinoma (mUC)
Presenter: Honey Kumar Oberoi
Session: E-Poster Display
Resources:
Abstract
778P - Concomitant antibiotic use and its effect on immune-checkpoint inhibitor efficacy in patients with advanced urothelial carcinoma
Presenter: Mohammad Khan
Session: E-Poster Display
Resources:
Abstract